NMD4C Announces 2023 Early Career Award Recipients

We are excited to announce the recipients of the inaugural NMD4C Early Career Awards for 2023! This annual award program introduces three new awards, celebrating excellence and contribution to the neuromuscular field by early career investigators across both clinical and basic science streams.

This year, the NMD4C awarded three Early Career Awards as a part of this program: Early Career Biomedical Researcher of the Year, Early Career Clinical Researcher of the Year, and Early Career Publication of the Year.

We would like to congratulate this year’s recipients:

Early Career Biomedical Researcher of the Year award:

Dr. Nicolas Dumont, Associate professor, Rehabilitation department, University of Montreal

Early Career Clinical Researcher of the Year award:

Dr. Cam-Tu Émilie Nguyen, Neurologist, Assistant Professor, CHU Sainte-Justine, Université de Montréal

Early Career Publication of the Year:

Dr. Farshad Babaeijandaghi, Postdoctoral Fellow, Fabio Rossi Lab, University of British Columbia

“Metabolic reprogramming of skeletal muscle by resident macrophages points to CSF1R inhibitors as muscular dystrophy therapeutics”.


By creating these awards, the NMD4C provides a method of recognizing outstanding achievement by early career neuromuscular researchers and clinicians on behalf of the Canadian neuromuscular community. Recipients receive a tangible accolade to bolster their academic CVs in pursuit of future academic appointments and grant applications. This award program is a part of the network’s broader strategy to provide support for Canadian early-career neuromuscular investigators.


“Early career investigators are at a stage in their careers where finding the funding and academic appointments to continue their research programs and clinical work is integral to their career progression in the field of neuromuscular care and research. These applications are highly competitive, and it is our hope that receiving an NMD4C award can help support and strengthen these applications to secure important research funding and academic appointments.”

  • Dr. Natasha Chang, Assistant Professor, Department of Biochemistry, McGill University and NMD4C Early-Career working group member


Thank you to all those who submitted nominations for these awards; we received many strong applications, and we look forward to hosting these awards again for the coming year. More information on the application process for 2024 is available on our awards page.

Congratulations to the early career award recipients! Photos of the three recipients, with text reading biomedical researcher of the year, clinical researcher of the year, publication of the year.

Read next...

Defeat Duchenne Canada logo.

Defeat Duchenne Canada launches 2023 Research Grant Program

DDC invites research proposals for their 2023 research grant program of a translational or clinical nature focused on improving the health and quality of life for individuals living with Duchenne muscular dystrophy.

Oskoui clinical trial graphic_4x3

Investigator Dr. Maryam Oskoui Receives CIHR Grant to Fund Spinal Muscular Atrophy Clinical Trial

NMD4C investigator Dr. Maryam Oskoui was awarded a Canadian Institutes of Health Research Clinical Trials Operating Grant for INFORM SMA as nominated principal applicant.

JP LG mytho study4x3

Early Career member Dr. Jean-Philippe Leduc-Gaudet identifies gene involved in regulating autophagy and skeletal muscle integrity

NMD4C early career member, Dr. Jean-Philippe Leduc-Gaudet, has made a significant discovery by identifying a novel gene that plays a key role in regulating autophagy and skeletal muscle health

BIND study poster; graphic of computer and scale in centre, NMD4C logo with MDC and CNDR, OHRI in top right and link to study below.

New CIHR-funded Burden of Inherited Neuromuscular Disease (BIND) Study: Assessing the Indirect Socio-Economic Burden of Inherited Neuromuscular Diseases

The BIND study’s goal is to assess the social and economic burden of Canadians living with neuromuscular disorders by using web-based surveys to assess quality-of-life, healthcare resource use, work productivity, and effect on schooling and careers.

text reading Canadian FSHD registry, with icons in centre of page and CNDR and MDC logos underneath.

Muscular Dystrophy Canada, Canadian Neuromuscular Disease Registry, NMD4C partner to ensure Canadians can access Facioscapulohumeral muscular dystrophy (FSHD) cure(s)

MDC and the CNDR are working together with NMD4C to introduce a patient registry and collect information to build a Canada-wide core dataset for FSHD.

NMD4C 2022 year in review poster

2022 NMD4C Year in Review

The NMD4C would like to reflect on all the inspiring progress the network has made towards the network’s goals in 2022. This year in review outlines a collection of achievements from the network over the past year.